- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06033664
Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes
May 9, 2024 updated by: Alison Gustafson
The purpose of this study is to evaluate the effectiveness of a grocery prescription program in adults diagnosed with either Type 2 Diabetes Mellitus or Hypertension.
Participants will enroll in Instacart Fresh Funds program.
Once enrolled each week participants will select foods that are eligible in the Fresh Funds Program to be delivered to their home for 12 weeks.
Participants will also participate in a survey at the beginning of the study and at the end of the study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40506
- University Of Kentucky
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of Type 2 Diabetes Mellitus, hemoglobin A1c = 7.0% and = 12.0% in last 12 months, or diagnosis of hypertension
- Experiencing food insecurity as indicated by 2-item Hunger Vital Sign
- English speaking
- No plans to move from the area for at least 1 year
- Willing and able to accept text messages
- Free living to the extent that participant has control over dietary intake
- Willing and able to provide written informed consent and participate in all study activities.
Exclusion Criteria:
- Participant in diabetes, nutrition, or weight research intervention in last 12 months
- Another member of the household is already enrolled in this study
- Considering bariatric surgery in the next year or prior bariatric surgery
- Lack of safe, stable residence and ability to store meals
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Grocery Prescription Program
Participants will receive the Fresh Funds through Instacart
|
Participants will enroll in Instacart Fresh Funds program.
Once enrolled participants will select foods that are eligible in the Fresh Funds to be delivered to their home each week for 12 weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with a percentage change in Hemoglobin A1C (HbgA1C)
Time Frame: baseline and post intervention, approximately 12 weeks
|
HbgA1C will be obtained baseline and post intervention by the healthcare provider from the medical chart.
|
baseline and post intervention, approximately 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in food insecurity
Time Frame: baseline and post intervention, approximately 12 weeks
|
The USDA 6 item food insecurity screener will be used.
The scale ranges from 0 to 6 with a higher score indicating greater food insecurity.
|
baseline and post intervention, approximately 12 weeks
|
|
Change in blood pressure
Time Frame: baseline and post intervention, approximately 12 weeks
|
Both systolic and diastolic blood pressure will be obtained baseline and post intervention by the healthcare provider from the medical chart.
|
baseline and post intervention, approximately 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alison Gustafson, PhD, University Of Kentucky
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 6, 2023
Primary Completion (Actual)
May 8, 2024
Study Completion (Actual)
May 8, 2024
Study Registration Dates
First Submitted
September 5, 2023
First Submitted That Met QC Criteria
September 5, 2023
First Posted (Actual)
September 13, 2023
Study Record Updates
Last Update Posted (Actual)
May 10, 2024
Last Update Submitted That Met QC Criteria
May 9, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 88696
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Fresh Funds
-
University of PennsylvaniaActive, not recruiting
-
University of North Carolina, GreensboroNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Duke...RecruitingBreastfeeding Support | Breastfeeding Duration | Breastfeeding Continuation | Breastfeeding Self-EfficacyUnited States
-
Alison GustafsonInstacart Health; Kentucky Association of Health PlansCompletedType 2 Diabetes Mellitus | Gestational Diabetes Mellitus in PregnancyUnited States
-
Bangladesh Agricultural UniversityCompletedGastrointestinal Diseases | Foodborne Diseases | Escherichia Coli | Microbial Contamination | Street Vended Foods | S. Aureus | Total Viable CountBangladesh
-
Xinqiao Hospital of ChongqingUnknown
-
University of ArizonaArizona State University; El Rio Community Health CenterEnrolling by invitationDiabetes Mellitus, Type 2United States
-
Rigshospitalet, DenmarkUnknownSurgery | Ischemic Reperfusion Injury | Abdominal Aortic AneurismDenmark
-
Montefiore Medical CenterUnited States Department of Agriculture (USDA)RecruitingDiabetes | PreDiabetes | Food InsecurityUnited States
-
Huiqing SunMount Sinai Hospital, Canada; Children's Hospital of Fudan University; The Third... and other collaboratorsCompletedNecrotizing EnterocolitisChina